데.일.리.카.창.간.10.주.년
최신기사
목록

기사공유

GM Korea stopped producing Alpheon, actually discontinued

GM Korea stopped producing Alpheon, actually discontinuedChevrolet
2015-08-18 12:55 등록   3,199 읽음
[사진] 알페온


[by Kim, Song-Yi] GM Korea′s Alpheon will be discontinued soon.

GM Korea changed its plan from that GM would continue to keep Alpheon′s sale by the end of this year or the beginning of the next year into that GM stopped whole process of producing Alpheon from this month.

Thus, after arranging stock by next month, Alpheon, in fact, will be discontinued.

[사진] 럭셔리세단 알페온


An officer from GM Korea said on August 12th that, ″Alpheon which had been produced in Bupyeong plant was stopped producing from this August.″

He added, ″Alpheon will be sold by clearing out stock. (Since there are not as many stocks as being thought) It seems that Alpheon will be able to be sold by September.″

Alpheon has been sold since 2010 August. 5,886 units were sold in 2010, 10,292 units in 2011, 7,008 units in 2012, 3,921 units in 2013, 5,013 units in 2014, and 2,301 units have been sold in 2015 so far. Only 34,421 units have been sold for 5 years.

[사진] Alpheon


GM Korea expected that about 100,000 units of Alpheon could be sold when Alpheon was first released in Korean market.

Also, GM Korea will concentrate more on Chevrolet′s Impala which has played quite well in the market.

Meanwhile, free-interest installment plan is offered for all Alpheon customers in August, and additional 2,000,000 won will be discounted as fees for holiday.


[사진] 럭셔리세단 알페온


by Kim, Song-Yi sykim@dailycar.co.kr
클래스가 다른; 자동차 뉴스 채널 데일리카 http://www.dailycar.co.kr
본 기사를 이용하실 때는 출처를 밝히셔야 하며 기사전재 및 재배포를 금합니다.

  • [시승기] 기아차 K3 GT..“보기에도 좋고 운전도 재밌다”
  • 한국지엠이 하반기 투입 확정한 트래버스·콜로라도..특징은?
  • [김필수 칼럼] 완성차의 편의장치 극대화..중소기업의 불편한 진실은?
  • 맥라렌, 가장 빠른 ‘세나 GTR’ 양산형 모델 공개..825 마력 파워
  • 아디다스, 프레데터 출시 25주년 기념..특별 한정판 축구화 공개
  • 수입 SUV의 중심, 랜드로버 레인지로버..2세대 이보크의 ′진화′
  • 생산 취소됐던 레인지로버 SV 쿠페..英 코치빌더 통해 ‘부활’
  • BMW, 신형 7시리즈 생산 착수..올해 국내 투입 계획
COPYRIGHT ⓒ 데일리카 WWW.DAILYCAR.CO.KR   ALL RIGHTS RESERVED.